This independent lab test from Janoshik Labs confirms Tirzepatide 40mg from Skye Peptides at 99.872% purity. The analysis was conducted on February 12, 2025, with tested quantity of 42.58mg. Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its potential effects on metabolic regulation, weight management, and glycemic control. The high purity level of 99.872% indicates minimal contamination and high-grade synthesis quality. The tested quantity of 42.58mg exceeds the stated label claim of 40mg, demonstrating product integrity. The full certificate of analysis is available for verification on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.